Physical activity and dietary counselling slows down the development of insulin resistance in children
A new study from the University of Eastern Finland shows that individualised and family-based physical activity and dietary counselling considerably slows down the development of insulin resistance, which…
A glucose-lowering drug can protect kidneys in type 1 diabetes patients
Dapagliflozin, can protect the kidneys in patients with type 1 diabetes. According to results shown in a new study published in the Lancet.
Newer Type 2 diabetes medications have heart and kidney disease benefits, too
Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD)…
Study shows both natural variation in ACE concentrations and lowering blood pressure with ACE inhibitors are associated with lower risk of type 2 diabetes
New research shows that usage of angiotensin-converting enzyme (ACE) inhibitors to lower blood pressure, is associated with a 24% reduced risk of developing type 2 diabetes (T2D) when…
Ketoacidosis and high-blood sugar comas in patients with type 1 diabetes linked to increased risk of suicide attempt
All patients hospitalised for ketoacidosis/comas should have a psychiatric assessment